跳到正文

Baker Brothers Life Sciences LP 内部人交易:近期 SEC Form 4 交易

过去 18 个月,Baker Brothers Life Sciences LP(CIK 1363364)在 11 家公司共报告 201 笔 SEC Form 4 内部人交易(最近一笔 2026-11-06)。

日期公司身份类型股数市值
2026-11-06Kodiak Sciences Inc. (KOD)董事买入8,742$861,174
2026-11-06MADRIGAL PHARMACEUTICALS, INC. (MDGL)董事买入5,586$2.1M
2026-11-06Kodiak Sciences Inc. (KOD)董事买入151,916$15.0M
2026-11-06MADRIGAL PHARMACEUTICALS, INC. (MDGL)董事买入10,080$3.7M
2026-11-06Kodiak Sciences Inc. (KOD)董事买入4,703$463,293
2026-11-06MADRIGAL PHARMACEUTICALS, INC. (MDGL)董事买入60,400$23.1M
2026-11-06Kodiak Sciences Inc. (KOD)董事买入81,729$8.1M
2026-11-06MADRIGAL PHARMACEUTICALS, INC. (MDGL)董事买入13,740$5.3M
2026-11-06MADRIGAL PHARMACEUTICALS, INC. (MDGL)董事买入2,000$793,220
2026-10-02INCYTE CORP (INCY)董事买入322$0
2026-10-02INCYTE CORP (INCY)董事买入322$0
2026-09-30Kodiak Sciences Inc. (KOD)董事买入3,114$270,046
2026-09-30Kodiak Sciences Inc. (KOD)董事买入186$16,130
2026-09-30Kodiak Sciences Inc. (KOD)董事买入957$83,077
2026-09-30Kodiak Sciences Inc. (KOD)董事买入16,036$1.4M
2026-09-30Kodiak Sciences Inc. (KOD)董事买入3,790$329,503
2026-09-30Kodiak Sciences Inc. (KOD)董事买入63,539$5.5M
2026-09-30Kodiak Sciences Inc. (KOD)董事买入4,485$392,482
2026-09-30Kodiak Sciences Inc. (KOD)董事买入75,176$6.6M
2026-09-30Kodiak Sciences Inc. (KOD)董事买入5,880$520,792
2026-09-30Kodiak Sciences Inc. (KOD)董事买入98,561$8.7M
2026-09-30Kodiak Sciences Inc. (KOD)董事买入6,428$569,842
2026-09-30Kodiak Sciences Inc. (KOD)董事买入107,772$9.6M
2026-09-30Kodiak Sciences Inc. (KOD)董事买入4,932$441,907
2026-09-30Kodiak Sciences Inc. (KOD)董事买入82,673$7.4M

来源:SEC Form 4 申报文件 · 截至 2026-11-06